The Third Street Garage across from the new Chase Center will soon be transformed into a visually stimulating anchor structure, complementing the rapidly changing Mission Bay neighborhood and amplifying UCSF’s scientific brand.
UCSF is opening a pioneering cancer center devoted to providing adult patients with highly advanced treatments, including immunotherapy, genetic counseling, molecular profiling of tumors, fully integrated clinical trials, and advanced imaging.
UCSF Health is opening a pioneering Precision Cancer Medicine Building devoted to bringing together the leading science with patient-centered care to provide patients with the most advanced, personalized treatments.
A Phase 3 study has found that patients with Sickle Cell Disease (SCD) who took a daily dose of the novel drug voxelotor had less anemia and made healthier red blood cells than patients receiving a placebo.
Research identifies enzymes produced by two different bacterial species that work together to digest L-Dopa in the human gut. Blocking one of these bacterial enzymes could significantly boost the drug’s efficacy in these patients.
An international study may offer hope to people with a rare and debilitating genetic disorder, PKAN, as well as a potentially new approach to treat other neurodegenerative disorders, such as Alzheimer’s, Parkinson’s disease and multiple sclerosis.
Two-day symposium will bring together scientists from a variety of disciplines to discuss emerging trends in diseases such as Lyme, malaria, dengue, Zika and others that are transmitted by mosquitos, ticks, flies and other arthropod vectors.